XSWX
CLTN
Market cap392mUSD
Apr 09, Last price
56.10CHF
1D
-2.09%
1Q
10.87%
Jan 2017
-24.24%
IPO
-36.25%
Name
Coltene Holding AG
Chart & Performance
Profile
COLTENE Holding AG develops, manufactures, and sells disposables, tools, and equipment for dentists and dental laboratories in Europe, the Middle East, Africa, North America, Latin America, and Asia/Oceania. It offers restoration products, including conventional composites, bulk-fill composites, CAD/CAM solutions, core build-ups, bondings, etching gels, temporary materials, luting, curing lights, and characterizations; and endodontics products, such as posts, rotary and hand files, irrigation solutions, obturation and sealing materials, Gutta-percha and paper points, endo engines, apex locators, and endo accessories. The company also provides prosthetics comprising bite registration, retractions, A-silicones, C-silicones, and accessories; and treatment auxiliaries consisting of dental rolls and dispensers, cotton pellets and dispensers, aspirator tips, dental dams and dam kits, dental dam clamps and accessories, dental scalers, electrosurgery, and occlusion verification products. In addition, it offers infection control products, which include ultrasonic cleaning units, patient bibs, headrest covers, and sterile covers; rotary instruments, such as diamond and carbide burs, polishers, kits, and accessories; and laboratory products comprising gingiva masks, lab putty products, model making products, waxes, occlusion control products, accessories, HP burs, and silicone polishers. The company was formerly known as Medisize Holding AG and changed its name to COLTENE Holding AG in April 2008. COLTENE Holding AG was incorporated in 2005 and is headquartered in Altstätten, Switzerland.
Valuation
Title CHF in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 242,729 -9.13% | 267,125 -4.34% | |||||||
Cost of revenue | 127,806 | 140,723 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 114,923 | 126,402 | |||||||
NOPBT Margin | 47.35% | 47.32% | |||||||
Operating Taxes | 4,171 | 6,936 | |||||||
Tax Rate | 3.63% | 5.49% | |||||||
NOPAT | 110,752 | 119,466 | |||||||
Net income | 11,947 -54.05% | 25,999 -18.00% | |||||||
Dividends | (19,711) | (19,716) | |||||||
Dividend yield | 4.61% | 4.33% | |||||||
Proceeds from repurchase of equity | (153) | (353) | |||||||
BB yield | 0.04% | 0.08% | |||||||
Debt | |||||||||
Debt current | 45,000 | 47,072 | |||||||
Long-term debt | 67 | ||||||||
Deferred revenue | |||||||||
Other long-term liabilities | 2,314 | 2,461 | |||||||
Net debt | 26,363 | 22,544 | |||||||
Cash flow | |||||||||
Cash from operating activities | 25,976 | 23,421 | |||||||
CAPEX | (6,869) | (8,318) | |||||||
Cash from investing activities | (8,561) | (8,197) | |||||||
Cash from financing activities | (21,935) | (15,928) | |||||||
FCF | 120,099 | 109,582 | |||||||
Balance | |||||||||
Cash | 18,360 | 24,224 | |||||||
Long term investments | 277 | 371 | |||||||
Excess cash | 6,501 | 11,239 | |||||||
Stockholders' equity | 96,880 | 338,103 | |||||||
Invested Capital | 137,687 | 147,919 | |||||||
ROIC | 77.56% | 83.11% | |||||||
ROCE | 78.29% | 78.01% | |||||||
EV | |||||||||
Common stock shares outstanding | 5,975 | 5,975 | |||||||
Price | 71.60 -6.04% | 76.20 -32.21% | |||||||
Market cap | 427,821 -6.03% | 455,261 -32.21% | |||||||
EV | 454,184 | 477,805 | |||||||
EBITDA | 121,772 | 133,117 | |||||||
EV/EBITDA | 3.73 | 3.59 | |||||||
Interest | 837 | 232 | |||||||
Interest/NOPBT | 0.73% | 0.18% |